« Back to Record
Citation APA

Köhne, C. H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K. H., Braumann, D., Joosens, E., Müller, L. P., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H. J., Bleiberg, H., Van den Brande, J., Debois, M., Bethe, U., & Van Cutsem, E. (2008). Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. Annals of oncology, 19(5), 920-926. doi:10.1093/annonc/mdm544


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/90252

Köhne, C. H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K. H., Braumann, D., Joosens, E., Müller, L. P., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Späth-Schwalbe, E., Wilke, H. J., Bleiberg, H., Van den Brande, J., Debois, M., Bethe, U., & Van Cutsem, E. (2008). Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. Annals of oncology, 19(5), 920-926. doi:10.1093/annonc/mdm544